Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its use

Detalles Bibliográficos
Autor principal: Scott, Lesley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325092/
https://www.ncbi.nlm.nih.gov/pubmed/31186615
http://dx.doi.org/10.1007/s40267-018-0594-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325092/
https://www.ncbi.nlm.nih.gov/pubmed/31186615
http://dx.doi.org/10.1007/s40267-018-0594-z

Ejemplares similares